Navigation Links
Pediatrics Group Issues New Ear Infection Guidelines
Date:2/25/2013

If children who are being observed don't improve within 48 to 72 hours from when symptoms first began, the guidelines recommend beginning antibiotic therapy.

Previous guidelines recommended giving antibiotics for ear infections in children age 2 and under. The new guidelines suggest that children aged between 6 months and 23 months can be observed with close follow-up as long as they don't have severe symptoms.

Another key component of the new guidelines is pain management. "Antibiotics take 24 to 48 hours before they start to improve signs and symptoms, so if a child has fever or pain, it's important to place them on [pain-relieving or fever-reducing medications]," Samuels said.

The guidelines also confirm that amoxicillin should be the antibiotic of choice unless the child is allergic to penicillin, or if the child has been treated with amoxicillin during the past month.

The new guidance from the AAP also states that children, even those with recurrent infections, shouldn't be on long-term daily antibiotics to try to prevent infections from occurring.

Children who have three or more ear infections in a six-month period, or four or more infections in a one-year period (with at least one infection occurring in the previous six months), should be referred to an ear, nose and throat specialist. That's because children with such frequent infections may need to have tubes placed in their ears for better fluid drainage.

Finally, the guidelines also recommend staying current on your child's vaccine schedule, particularly with the pneumococcal conjugate vaccine (PCV), and the annual flu shot.

"Studies show that anything that decreases viral infection will decrease the incidence of [ear infections]," Lieberthal said.

Both Lieberthal and Samuels said that parents increasingly understand the importance of trying to reduce the use of antibiotics. First, because it exposes their child to unnecessary risks from side effect
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Westminster Pediatrician Residents Love Encourages Flu Shots for the Whole Family at Indian Crest Pediatrics
2. Frontiers launches new open-access journal: Frontiers in Pediatrics
3. Cell Phones and Brain Cancer: American Academy of Pediatrics Endorses Cell Phone Right to Know Act, Bernstein Liebhard LLP Reports
4. Results from study of Mead Johnsons Enfamil® Human Milk Fortifier Acidified Liquid published in Pediatrics
5. Cunningham Financial Group Encourages Residents of Louisiana to Celebrate American Heart Month
6. Nashville Periodontal Group Is Expanding Their Sedation Dentistry To Include Patients In Forest Hills, TN Needing Dental Anxiety Relief
7. Bedford Dental Group Offers Dental Implant Special on bhdentists.com - LAD Solutions to Handle the Promotion
8. US Drug Watchdog Now Urges Any Woman Who had A Out Of The Blue Stroke Or Heart Attack After Using Birth Control Pills Call Yaz, Or Yasmin to Call the Johnson Law Group
9. 2013 Top Black Book Electronic Health Records (EHR) Systems Announced for Ambulatory Physician Groups
10. Lupus Support Group in Northwest Detroit March 16th
11. Lupus Support Group in Jackson, Michigan on March 13th
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pediatrics Group Issues New Ear Infection Guidelines
(Date:7/30/2014)... 2014 According to the market ... Market by Technology (ICS, MES, ERP, ITS), Field ... FGOL), Application (Process, Discrete) - Global Forecast & ... the Mexican market is expected to reach $6.99 ... , Browse 70 market data Tables and 96 ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 The North ... 1781.02 million by 2019. North America is expected to ... actuation market at a CAGR of 5.60%. , ... opportunities and challenges which will assume prominence in the ... the past, yet the sector has regained quickly, and ...
(Date:7/30/2014)... Vedic Studies (WAVES) conference is coming to Fairfield, Iowa,s ... through Sunday, August 3. To watch the main plenary ... first time such a large and diverse group of ... explore the relevance of ancient Vedic knowledge in today,s ... of consciousness, and reflections on the various Vedic texts. ...
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- Medical costs for ... are more than $32 billion each year, according to ... and Prevention. The yearly financial toll of COPD ... reach an estimated $49 billion by 2020. "For ... COPD, which provide state public health practitioners with estimates ...
(Date:7/30/2014)... This news release is available in French . ... Inserm, led by Claude Gronfier (Inserm Unit 846: Stem ... conducted a study under real conditions on the body ... Concordia. The researchers have shown that a particular kind ... biological rhythms are correctly synchronised despite the absence of ...
Breaking Medicine News(10 mins):Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 4Health News:North America Aviation Actuation System Market is Expected to Reach $1781.02 million in 2019 - New Report by MicroMarket Monitor 2Health News:North America Aviation Actuation System Market is Expected to Reach $1781.02 million in 2019 - New Report by MicroMarket Monitor 3Health News:North America Aviation Actuation System Market is Expected to Reach $1781.02 million in 2019 - New Report by MicroMarket Monitor 4Health News:Vedic living in a modern world: International conference at Maharishi University 2Health News:Vedic living in a modern world: International conference at Maharishi University 3Health News:Annual COPD Costs To Hit $49 Billion by 2020: CDC 2Health News:Dimly lit working environments: Correcting your body clock is possible! 2Health News:Dimly lit working environments: Correcting your body clock is possible! 3Health News:Dimly lit working environments: Correcting your body clock is possible! 4
... 22 ResMed Inc. (NYSE: RMD ), announced ... its results for the third quarter and nine months of ... with ResMed,s results will be issued after 1:00 p.m. Pacific ... webcast to review its results, market trends, and future outlook.The ...
... study finds older people taking NSAIDs more likely to suffer ... suggested that older people who want to avoid Alzheimer,s disease ... ibuprofen and naproxen, but a new study suggests that might ... ,Should I take these to prevent dementia?, the answer ...
... BALTIMORE, April 22 XLHealth, owner and operator of ... Advantage chronic condition Special Needs Plans, supports the proposed ... in the first of a series of round-table discussions ... The hearing,s focus on using the Medicare system as ...
... professional groups join with Congressional sponsors Reps. Israel, Brady ... access to IVIGWASHINGTON, April 22 Members ... introduction of new legislation - H.R. 2002, Medicare Patient ... inadequate Medicare reimbursements that currently restrict patient access to ...
... Study finds no link to condition that can increase ... Soy isoflavones don,t increase breast density, a new study ... increased breast density is associated with a higher risk ... that dietary factors, including isoflavones (estrogen-like plant compounds) might ...
... New York Times best-selling author and mother of five ... special family gathering to celebrate her status as a mom. Instead, ... seeking favors and just plain hard work. Novak,s 5th Annual Online ... May is a labor of love for her son who has ...
Cached Medicine News:Health News:ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2009 Results 2Health News:Painkillers May Not Protect Against Dementia 2Health News:Painkillers May Not Protect Against Dementia 3Health News:XLHealth Statement on Senate Finance Committee Roundtable on Healthcare Reform 2Health News:New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 2Health News:New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 3Health News:New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 4Health News:NY Times Best-Selling Author Brenda Novak Gives Annual Mother's Day Gift of Hope to Diabetic Son and Others 2Health News:NY Times Best-Selling Author Brenda Novak Gives Annual Mother's Day Gift of Hope to Diabetic Son and Others 3Health News:NY Times Best-Selling Author Brenda Novak Gives Annual Mother's Day Gift of Hope to Diabetic Son and Others 4
(Date:7/30/2014)... , July 30, 2014  Regeneron Pharmaceuticals, Inc. ... and NYSE: SNY ) today announced that ... people with hypercholesterolemia met their primary efficacy endpoint of ... cholesterol (LDL-C) at 24 weeks compared to placebo or ... PCSK9 (proprotein convertase subtilisin/kexin type 9). In ...
(Date:7/30/2014)... and NEW YORK , ... ACCP), a developer of new products for oncology supportive ... MuGard ® , has been featured in an article ... Mucositis Symptoms in Head and Neck Cancers."  Dr. ... provides insight on the growing demand seen in the ...
(Date:7/30/2014)... 2014   Bluegrass Vascular Technologies , a ... devices and methods for vascular access, today announced ... financing, which was led by Targeted Technology ... allow Bluegrass Vascular to obtain CE Mark for ... capabilities, and proceed with US regulatory submissions. The ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Medicine Products: